Products

BioMarin has developed and commercialized three products in ten years, a remarkable accomplishment in the biopharmaceutical industry, and a testament to the company’s passion and dedication to patients with serious, unmet medical needs.

Products on the Market

BioMarin has three approved products on the market today:

• Kuvan^® (sapropterin dihydrochloride) Tablets for PKU
• Naglazyme^® (galsulfase) for MPS VI
• Aldurazyme^® (laronidase) for MPS I

For full prescribing information, please visit www.kuvan.com, www.naglazyme.com, and www.aldurazyme.com.

• Overview
• Naglazyme^®
• Aldurazyme^®
• Kuvan^®